On July 17, Twist Bioscience fell 5.24% in regular trading, trading at $91.11 USD/share, with Turnover of $23.59 million.
Within the Biotechnology sector where Twist Bioscience belongs, major sector peers showed gains. Among individual stocks, AbbVie up 1.31%, Amgen up 0.4%, Gilead Sciences up 1.57%, Vertex Pharmaceuticals up 0.91%, ORUKA THERAPEUTICS INC up 6.17%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)